Literature DB >> 27407796

Platelet Functions in Cardiopulmonary Bypass Surgery.

S J Varghese1, M K Unni2, N Mukundan3, Ramji Rai4.   

Abstract

BACKGROUND: Haemorrhage after Cardio Pulmonary Bypass (CPB) Surgery is a well recognised complication that leads to significant morbidity and mortality. The incidence varies between 5-25% depending upon the clinical situation. Several factors are implicated as causative but none have been precisely proved.
METHODS: Our study was an attempt to evaluate the haemostatic defect with particular reference to platelet function abnormalities during cardio pulmonary bypass surgery, in order to reduce the morbidity and mortality associated with post CPB haemorrhage. Flow cytometric evaluation of different platelet glycoproteins like GPIb/IX, GPIIb/IIIa and GMP-140 was done.
RESULTS: The marker expression showed deregulation during surgery which returned to base after bypass was terminated. In contrast, the cases with bleeding showed significant variation. P-Selectin (GMP 140) expression decreased progressively till 3(rd) post-operative day showing lack of activation of platelets in cases of severe bleeding.
CONCLUSION: Longer duration of CPB initiates plasmin generation through heparin, which raises the PAI-1-tPA complex and thereby down regulating the functions of platelets. This suggests a link between duration of CPB, bleeding, platelet dysfunction and fibrinolysis. Hence serial estimations of the levels of GMP-140 and tPA can predict severe bleeding.

Entities:  

Keywords:  CardioPulmonary Bypass; Platelet dysfunction; flowcytometry; haemorrhage; platelet glycoproteins

Year:  2011        PMID: 27407796      PMCID: PMC4922914          DOI: 10.1016/S0377-1237(05)80053-X

Source DB:  PubMed          Journal:  Med J Armed Forces India        ISSN: 0377-1237


  13 in total

1.  Modulation of platelet surface adhesion receptors during cardiopulmonary bypass.

Authors:  C S Rinder; J P Mathew; H M Rinder; J Bonan; K A Ault; B R Smith
Journal:  Anesthesiology       Date:  1991-10       Impact factor: 7.892

2.  The platelet function defect of cardiopulmonary bypass.

Authors:  A S Kestin; C R Valeri; S F Khuri; J Loscalzo; P A Ellis; H MacGregor; V Birjiniuk; H Ouimet; B Pasche; M J Nelson
Journal:  Blood       Date:  1993-07-01       Impact factor: 22.113

3.  Cardiopulmonary bypass leads to a preferential loss of activated platelets. A flow cytometric assay of platelet surface antigens.

Authors:  A Wahba; G Black; M Koksch; G Rothe; J Preuner; G Schmitz; D E Birnbaum
Journal:  Eur J Cardiothorac Surg       Date:  1996       Impact factor: 4.191

4.  A prospective, randomized study of cardiopulmonary bypass temperature and blood transfusion.

Authors:  P E Stensrud; G A Nuttall; M A de Castro; M D Abel; M H Ereth; W C Oliver; S C Bryant; H V Schaff
Journal:  Ann Thorac Surg       Date:  1999-03       Impact factor: 4.330

Review 5.  Bleeding complications associated with cardiopulmonary bypass.

Authors:  R C Woodman; L A Harker
Journal:  Blood       Date:  1990-11-01       Impact factor: 22.113

6.  Aprotinin protects platelets against the initial effect of cardiopulmonary bypass.

Authors:  W van Oeveren; M P Harder; K J Roozendaal; L Eijsman; C R Wildevuur
Journal:  J Thorac Cardiovasc Surg       Date:  1990-05       Impact factor: 5.209

7.  Progressive platelet activation with storage: evidence for shortened survival of activated platelets after transfusion.

Authors:  H M Rinder; M Murphy; J G Mitchell; J Stocks; K A Ault; R S Hillman
Journal:  Transfusion       Date:  1991-06       Impact factor: 3.157

8.  Preoperative platelet dysfunction increases the benefit of aprotinin in cardiopulmonary bypass.

Authors:  M J Ray; N A Marsh; S J Just; E J Perrin; M F O'Brien; G A Hawson
Journal:  Ann Thorac Surg       Date:  1997-01       Impact factor: 4.330

9.  Normothermia versus hypothermia during cardiopulmonary bypass: a randomized, controlled trial.

Authors:  M Tönz; T Mihaljevic; L K von Segesser; E R Schmid; H I Joller-Jemelka; P Pei; M I Turina
Journal:  Ann Thorac Surg       Date:  1995-01       Impact factor: 4.330

10.  Platelet surface glycoproteins. Studies on resting and activated platelets and platelet membrane microparticles in normal subjects, and observations in patients during adult respiratory distress syndrome and cardiac surgery.

Authors:  J N George; E B Pickett; S Saucerman; R P McEver; T J Kunicki; N Kieffer; P J Newman
Journal:  J Clin Invest       Date:  1986-08       Impact factor: 14.808

View more
  2 in total

1.  Postoperative Complications Are Not Elevated in Well-Compensated ESRD Patients Undergoing Cardiac Surgery: End-Stage Renal Disease Cardiac Surgery Outcomes.

Authors:  Benjamin R Griffin; Patrick D Kohtz; Michael Bronsert; T Brett Reece; Joseph C Cleveland; David A Fullerton; Sarah Faubel; Muhammad Aftab
Journal:  J Surg Res       Date:  2019-11-27       Impact factor: 2.192

2.  A novel autotransfusion device saving erythrocytes and platelets used in a 72 h survival swine model of surgically induced controlled blood loss.

Authors:  Kévin Schreiber; Benoit Decouture; Audrey Lafragette; Stéphane Chollet; Marine Bruneau; Maxence Nicollet; Catherine Wittmann; Francis Gadrat; Alexandre Mansour; Patricia Forest-Villegas; Olivier Gauthier; Gwenola Touzot-Jourde
Journal:  PLoS One       Date:  2022-03-24       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.